• Shuffle
    Toggle On
    Toggle Off
  • Alphabetize
    Toggle On
    Toggle Off
  • Front First
    Toggle On
    Toggle Off
  • Both Sides
    Toggle On
    Toggle Off
  • Read
    Toggle On
    Toggle Off
Reading...
Front

Card Range To Study

through

image

Play button

image

Play button

image

Progress

1/33

Click to flip

Use LEFT and RIGHT arrow keys to navigate between flashcards;

Use UP and DOWN arrow keys to flip the card;

H to show hint;

A reads text to speech;

33 Cards in this Set

  • Front
  • Back

common symptoms of depression

depressed mood and/or anhedonia


sad, guilt-ridden, hopelessness


nervous, irritable, agitated


somatic problems (physical problems)


psychosis

DMS-IV diagnostic criteria for MDD

must meet 5 of following criteria with at least 1 being depressed mood or anhedonia:


depressed mood, anhedonia, weight loss/gain, insomnia/hyperinsomnia, psychomotor agitation, fatigue or decreased energy, feelings of worthlessness, decreased concentration, recurrent thoughts of death

3 general factors related to the pathophysiology of depression

genetic predisposition, environment influences, biological factors

3 neurochemical transmitters thought to be involved in the pathology of depression

serotonin (5HT)


dopamine (DA)


norepinephrine (NE)

role of monoamine repuptake transporters in the pathology of depression

responsible for removing NTs from the synapse

role of monoamine oxidase in the pathology of depression

metabolizes monomines leading to decreased NT levels

major classifications of medications used to treat depression

selective serotonin reuptake inhibitors (SSRIs)


serotonin norepinephrine reuptake inhibitors (SNRIs)


atypical antidepressants


tricyclic antidepressants (TCAs)


trazodone


monoamine oxidase inhibitors (MAOIs)

MOA of SSRIs

inhibit serotonin transporter

MOA of SNRIs

inhibit neuronal repute of serotonin and norepinephrine

MOA of buproprion

inhibition of dopamine and norepinephrine reuptake

MOA of mirtazapine

enhances norephinephrine and serotonin activity

MOA of tricyclics

inhibition of norepinephrine and serotonin reuptake

MOA of trazodone

enhances serotonin activity

MOA of monoamine oxidase inhibitors

inhibits the enzyme responsible for metabolizing monoamines

ADRs of SSRIs

activation or sedation


nausea


sleep disturbances


sexual side effects


weight gain

ADRs of SNRIs

nausea, GI complaints, insomnia, sexual side effects, increased blood pressure, sweating, agitation

ADRs of buproprion

lowers seizure threshold


lower incidence of sexual side effects

ADRs of mirtazapine

sedating antihistaminic effect


significant weight gain


low rate of sexual dysfunction

ADRs of tricyclics

weight gain


glucose dysregulation


effects of cardiac conduction


very sedating


dry mouth, dry eyes, constipation, blurred vision


orthostasis

ADRs of trazodone

sedation


nausea


GI upset


priapism- erection lasting more than 4 hours

ADRs of monoamine oxidase inhibitors

a lot of side effects


extreme hypertension

response to treatment

significant reduction in, but not complete resolution of depressive symptoms

remission

complete resolution of depressive symptoms

recovery

sustained remission of at least 6 months

relapse

return of depressive symptoms within 6 months of achieving remission

recurrence

successive episode of MDD after recovery from initial episode of MDD

acute phase of depression treatment

initial 6-12 weeks of treatment

continuation phase of depression treatment

treatment bridging remission to recovery typically 6-9 months


continuation of antidepressant at full therapeutic dosage


antidepressant may be discontinued at the conclusion of the continuation phase

maintenance phase of depression treatment

continuation of an antidepressant at full therapeutic dosage for extended periods of time


not necessary for all patients


may be beneficial in patients at high risk of relapse or recurrence

how to manage insomnia due to antidepressants

reduce caffeine


morning dose


reduce dose


change antidepressant


adjunct with a sleep medication

how to manage anxiety due to antidepressants

minimize or avoid caffeine intake


reduce dose and titrate gradually


beta-blocker (slow heart rate)


benzodiazepine (anti-anxiety meds)

how to manage nausea due to antidepressants

start low, titrate dosage up


take with food


decrease dose


change antidepressant

how to manage sexual symptoms due to antidepressants

decrease antidepressant dose


switch to another antidepressant


add on a medication


wait to see if patient builds up a tolerance to the side effect